M6a-Mediated Upregulation of LINC00958 Increases Lipogenesis and Acts as a Nanotherapeutic Target in Hepatocellular Carcinoma

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0839-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Upregulation of T-Cell Factor-4 Isoform-Responsive Target Genes in Hepatocellular Carcinoma

Liver International
Hepatology
2013English

The Novel Gene MIA2 Acts as a Tumour Suppressor in Hepatocellular Carcinoma

Gut
Gastroenterology
2007English

MicroRNA-621 Acts as a Tumor Radiosensitizer via Directly Targeting SETDB1 in Hepatocellular Carcinoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Upregulation of Musashi1 Increases Malignancy of Hepatocellular Carcinoma via the WNT/Β-Catenin Signaling Pathway and Predicts a Poor Prognosis

BMC Gastroenterology
MedicineGastroenterology
2019English

UCK2 Upregulation Might Serve as an Indicator of Unfavorable Prognosis of Hepatocellular Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Profiles of M6A RNA Methylation Regulators for the Prognosis of Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2020English

DLK1 as a Potential Target Against Cancer Stem/Progenitor Cells of Hepatocellular Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

PI3Kδ Is a New Therapeutic Target in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates With Poor Survival in Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy